Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer

PURPOSE: To explore the immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in patients with breast cancer based on type of anticancer treatment. METHODS: Patients with breast cancer had anti-spike antibody concentrations measured ⩾14 days after receiving a full S...

Descripción completa

Detalles Bibliográficos
Autores principales: Denault, Elyssa, Nakajima, Erika, Naranbhai, Vivek, Hutchinson, Jennifer A., Mortensen, Lindsey, Neihoff, Elizabeth, Barabell, Caroline, Comander, Amy, Juric, Dejan, Kuter, Irene, Mulvey, Theresa, Peppercorn, Jeffrey, Rosenstock, Aron S., Shin, Jennifer, Vidula, Neelima, Wander, Seth A., Moy, Beverly, Ellisen, Leif W., Isakoff, Steven J., Iafrate, A. John, Gainor, Justin F., Bardia, Aditya, Spring, Laura M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425892/
https://www.ncbi.nlm.nih.gov/pubmed/36051470
http://dx.doi.org/10.1177/17588359221119370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425892/
https://www.ncbi.nlm.nih.gov/pubmed/36051470
http://dx.doi.org/10.1177/17588359221119370

Ejemplares similares